Personalizing cancer treatments for the youngest of patients

December 18, 2013 by Michele Fisher, Rutgers University

The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. Many of these targeted cancer therapies, however, have been more frequently identified for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey.

"Precision medicine constitutes a different method of identifying best treatment options for patients. Instead of prescribing therapy based solely on the organ where the cancer originated, clinicians utilize for a more comprehensive approach. Through a rapid gene sequencing test, the tiniest details of a tumor biopsy are uncovered, sometimes revealing one or more mutations in the patient's genes. It is the mutations themselves that can be targeted with new or existing drugs.

At the Cancer Institute of New Jersey, a team of physician-scientists, bioinformatics specialists, systems biologists, pathologists and a host of others meets weekly to discuss profiling results and determine therapy options. Currently, a genomic analysis clinical trial at the Cancer Institute is focused on those patients with rare or poor-prognosis cancers, including pediatric patients. It is the youngest of patients that Sherrie and Michael Wells, founders of Hugs for Brady, have focused their efforts and are hoping to help with their gift.

"The Kendall Park couple is no stranger to the work being done and care being provided at the Cancer Institute. Their son Brady Michael was treated there for acute undifferentiated leukemia before his passing in 2010, a few weeks shy of his second birthday. It was shortly after that they created the foundation with an aim of comforting children faced with cancer and providing resources to advance research in pediatric cancers and blood disorders.

Hugs for Brady founders Sherrie and Michael Well with Shridar Ganesan in his Rutgers Cancer Institute of New Jersey laboratory. Credit: Matt Rainey

Demonstrating its commitment to research, last year the foundation established the Hugs for Brady Foundation Pediatric Young Investigator Award at the Cancer Institute. The purpose of the two-year grant is to foster the early career development of promising young scientists while they pursue innovative research.

While pediatric cancer survivor rates are generally high, there are those children – like Brady – who unfortunately lose their fight due to rare forms of the disease. Hugs for Brady is committed to helping scientists further unlock the mysteries of rare pediatric cancers. By supporting the cutting-edge research and expert analysis being conducted through the precision medicine initiative at Rutgers Cancer Institute of New Jersey, we are moving closer to a cure," said Sherrie Wells.

"Recent research shows that more potential targets are being identified through genomic analysis for pediatric cancers. The commitment put forth by Hugs for Brady will help Cancer Institute investigators further build on those findings so that optimal treatments can be found for these young patients," said Shridar Ganesan, associate director for translational science at the Cancer Institute, who is the lead investigator of the genomic analysis trial and an associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School. "We are grateful to the Hugs for Brady Foundation for its continued dedication to the fight against pediatric cancer."

Explore further: Next-generation sequencing test identified potential targets for pediatric cancer treatments

Related Stories

Next-generation sequencing test identified potential targets for pediatric cancer treatments

November 5, 2013
A comprehensive genomic profiling test using next-generation sequencing has identified genomic alterations in more than half of pediatric cancer samples tested that would give clinicians potential targets on which to base ...

Gene sequencing project finds family of drugs with promise for treating childhood tumor

December 9, 2013
Drugs that enhance a process called oxidative stress were found to kill rhabdomyosarcoma tumor cells growing in the laboratory and possibly bolstered the effectiveness of chemotherapy against this aggressive tumor of muscle ...

Drug delivery system successfully treats deadly ovarian cancer in mice

December 6, 2013
(Medical Xpress)—Scientists at Rutgers University have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates for the most deadly gynecological cancer ...

Systems medicine paves the way for improved treatment for leukemia patients

December 12, 2013
A multi-disciplinary team of researchers at the Institute for Molecular Medicine Finland, FIMM, and the Helsinki University Central Hospital has developed a novel individualized systems medicine (ISM) strategy which enables ...

Major cancer genotyping study logs 5,000th tumor profile

September 12, 2013
More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the ...

Zebrafish shown to be useful tool in prostate cancer stem cell research

November 7, 2013
(Medical Xpress)—Research from Rutgers Cancer Institute of New Jersey demonstrates that using zebrafish to identify self-renewing tumor stem cells in prostate cancers may be more beneficial than using traditional experimental ...

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.